Akèy › Kansè vejik › Pennsylvania › Philadelphia
Etid klinik pou Kansè vejik nan Philadelphia, PA
21 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Ap rekriteFaz 3
- Fox Chase Cancer Center, Philadelphia
- Fox Chase Cancer Center-Rockledge, Rockledge · 10 mi lwen
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi lwen
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Ap rekriteFaz 2
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi lwen
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Ap rekriteFaz 2
- MidLantic Urology ( Site 0102), Bala-Cynwyd · 5 mi lwen
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Ap rekriteFaz 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi lwen
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Ap rekriteFaz 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
- Research Site, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Ap rekrite
- Fox Chase Cancer Center - Philadelphia, Philadelphia
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Ap rekriteFaz 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Ap rekriteEtid obsèvasyon
- University of Pennsylvania, Philadelphia
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Ap rekriteFaz 2
- University of Pennsylvania, Philadelphia
- Midlantic Urology (Solaris), Bala-Cynwyd · 5 mi lwen
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Ap rekriteFaz 1
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Ap rekriteFaz 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi lwen
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi lwen
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Ap rekriteFaz 1/2
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
- Thomas Jefferson University, Philadelphia
Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
Ap rekriteFaz 1
- University of Pennsylvania, Philadelphia
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
Ap rekrite
- Abramson Cancer Center, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- University of Pennsylvania, Philadelphia
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Ap rekrite
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Einstein Philadelphia Hospital, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Ap rekriteFaz 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Philadelphia
Etid Kansè vejik nan lòt vil
- New York City, NY35 etid
- Nashville, TN31 etid
- Houston, TX31 etid
- Dallas, TX27 etid
- Boston, MA26 etid
- Washington, DC26 etid
- Los Angeles, CA24 etid
- Baltimore, MD24 etid
- St. Louis, MO22 etid
- Seattle, WA21 etid
- Edison, NJ21 etid
- Chicago, IL21 etid
Lòt etid nan Philadelphia
- Kansè (tout kalite)59 etid
- Kansè nan tete56 etid
- Kansè Poumon ki pa ti selil51 etid
- Kansè Metastatik46 etid
- Kansè kolorektal44 etid
- Kansè ovè44 etid
- Kansè pwostat44 etid
- Kansè poumon36 etid
- Leksemi mieloïd egi34 etid
- Ensifizyans kadyak31 etid
- Kansè Endomèt28 etid
- Depresyon26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.